Navigation Links
Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles
Date:7/2/2008

currently in clinical development for a broad range of aesthetic and therapeutic applications including wrinkles, acne scars, burns and periodontal disease. Isolagen also commercializes a scientifically-advanced line of skincare systems through its majority-owned subsidiary, Agera(R) Laboratories, Inc. For additional information, please visit http://www.isolagen.com.

Isolagen Forward Looking Statements

All statements in this news release that are not based on historical fact are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include, without limitation, our ability to timely report the top-line efficacy and safety data from the Phase III studies during August 2008. While management has based any forward-looking statements contained herein on its current expectations, the information on which such expectations were based may change. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of risks, uncertainties, and other factors, many of which are outside of our control, that could cause actual results to materially differ from such statements. Such risks, uncertainties, and other factors include, but are not necessarily limited to, those set forth under Item 1A "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2007, as updated in "Item 1A. Risk Factors" in the Company's Quarterly Reports on Form 10-Q. We operate in a highly competitive and rapidly changing environment, thus new or unforeseen risks may arise. Accordingly, investors should not place any reliance on forward-looking statements as a prediction of actual results. We disclaim any intention to, and undertake no obligation to,
'/>"/>

SOURCE Isolagen, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase III Wrinkle and Phase II Full Face Studies
2. Isolagen, Inc. Completes Enrollment in Isolagen Therapy(TM) Phase II/III Acne Scar Study
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
6. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
9. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
10. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
11. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... DUBLIN , July 30, 2014 ... the "Global and Chinese Aseptic Packaging Industry Report ... http://photos.prnewswire.com/prnh/20130307/600769 The Global and ... in-depth study on the current state of the global ... situation. The report provides a basic overview of ...
(Date:7/30/2014)... --  Unique Pizza and Subs Corporation ("Unique," ... Delaware Corporation, is pleased to announce it has ... ("Larasan"), a nature-based pharmaceutical company that produces and distributes ... will work with Unique to help distribute its ... distribution network throughout China ...
(Date:7/30/2014)... and PARIS , July 30, ... ) and Sanofi (EURONEXT: SAN and NYSE: ... ODYSSEY trials of alirocumab in people with hypercholesterolemia met ... from baseline in low-density lipoprotein cholesterol (LDL-C) at 24 ... an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin ...
Breaking Medicine Technology:Global and Chinese Aseptic Packaging Industry Report 2014 2Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 2Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8
... , , BIRMINGHAM, Ala., Nov. 19 ... the pricing of a public offering of 5,000,000 shares of ... proceeds of $48.75 million. All of the shares are ... statement previously filed with the Securities and Exchange Commission. ...
... TAINAN, Taiwan, Nov. 19 /PRNewswire-Asia/ ... ingredients (APIs), announced that its,Tainan facility has received ... The Certification confirms ScinoPharm,s,competency and proficiency in the ... applies to specific laboratories and,production areas used for ...
Cached Medicine Technology:BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2
(Date:7/31/2014)... people are unaware of getting old. However, the truth is ... we were born on earth. Human beings will experience a ... people may live without children in their old age. In ... to worry about that. A lot of reliable enterprises are ... manufacturer , is one of them. The company is not ...
(Date:7/31/2014)... Care Communications, Inc., (CARE) a national health ... the Elite Award for “Recruitment, Selection and Orientation” from ... elite awards presented as part of “Chicago’s ... 2014 awards competition. This marks the seventh consecutive year ... competition. CARE has also been chosen as a national ...
(Date:7/31/2014)... Recently, iFitDress.com, a professional company of women’s ... by announcing a new collection of high low ... at very low prices. In addition, worldwide clients can ... officials want to save both time and money for ... shopping experience to all online visitors. On its website, ...
(Date:7/31/2014)... National non-profit World T.E.A.M. Sports’ annual ... Range September 12-14, following two years in the high ... of disabled and able-bodied athletes competing together in an ... challenging by experienced adventure athletes. , Hosted at the ... the Colorado River in the rugged Gore Mountains northwest ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 USHIO ... the specialty and general lighting marketplaces, today announced ... kits. These will allow users to transform existing, ... fixtures within minutes. , USHIO America’s Uphoria LED ... 6-inch downlight cans, allowing the user to upgrade ...
Breaking Medicine News(10 mins):Health News:FodayAuto.com: Do Not Be Afraid of Getting Old 2Health News:Care Communications, Inc. Named an Elite Award Winner Among Top Chicago Employers 2Health News:Discounted High Low Wedding Dresses Available At iFitDress.com 2Health News:World T.E.A.M. Sports’ Adventure Team Challenge Returns to Colorado’s High Country 2Health News:World T.E.A.M. Sports’ Adventure Team Challenge Returns to Colorado’s High Country 3Health News:USHIO America Introduces Uphoria™ LED Downlight Retrofit Kits 2
... well known, but a new study has found that it's ... they're given a rewarding task that tests their powers of ... and student colleague Michelle Corman studied men who were each ... raise their blood alcohol level to 0.1, slightly over the ...
... found a gene variant that raises a childs risk ... condition attributed to inflammation of the gastrointestinal tract . ... of a German study that identified the same gene ... disease is a chronic and painful condition attributed to ...
... Scientists have identified the first gene that is linked ... sleep disorder that affects millions of people worldwide . ... overpowering need to move the legs and is also ... ,,We now have concrete evidence that RLS is an ...
... for a swim only to be struck by flesh-eating ... in danger of losing a life, possibly even his ... a tissue-destroying disease caused by a bacterium called Vibrio ... suffering from multiple organ failure because the disease has ...
... revealed that the star had a miscarriage in 2005 . ... ever since they tied the knot in September 2005, and now ... star did in fact become pregnant, but she lost the baby. ... kids of her own. Demi and Ashton have been trying (to ...
... release of more than a thousand prisoners has failed ... and prisoner rehabilitation programmes, said the BMA today. ... anniversary of the Ministry of Justices introduction of emergency ... and Welsh prisons. A key element of the Government ...
Cached Medicine News:Health News:Alcohol may Help You to Be Cool 2Health News:Gene Variants for Crohn's Disease Identified 2Health News:Gene Variants for Crohn's Disease Identified 3Health News:Gene Linked With Restless Leg Syndrome Spotted Out 2Health News:Texan Battles Flesh-eating Bacteria Contracted While Swimming 2Health News:Prison Healthcare Continues to Fail Despite Emergency Measures, Warns BMA 2
... QuickThaw Plasma Thawing Systems from Helmer use both ... times while ensuring the safety of your plasma. ... models have dual baskets with independent controls that ... ,The QuickThaw is also convenient to operate, allowing ...
... systems are automated, easy to operate and ... outside environment by flexible snap-seal pockets which ... viral contamination of the water. Offered in ... can also accommodate bags of various sizes. ...
... Thawing Systems from Helmer use both controlled temperature ... ensuring the safety of your plasma. The DH4 ... dual baskets with independent controls that will accommodate ... is also convenient to operate, allowing you to ...
Inquire...
Medicine Products: